Devices › Ureteroscope and accessories, flexible/rigid
Device brand name · Ureteroscope and accessories flexible/rigid
LithoVue: medical device reports filed with FDA
192 reports name it, 2018–2026. Manufacturer given most often on reports: Boston Scientific. Product code FGB.
- 192
- device reports naming the brand
- 0% of all MAUDE reports · about 24 a year
- 18
- reports, 12 months to August 2026
- 18 in the 12 months before
- 64.6%
- classified as malfunction
- 89.3% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 192 reports that name the brand "LithoVue" (ureteroscope and accessories flexible/rigid), received between May 2018 and June 2026; the manufacturer given most often on reports is Boston Scientific. Spellings of one product vary from report to report.
18 reports arrived in the 12 months to August 2026, close to the 18 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (64.6%) and injury (34.9%); across all ureteroscope and accessories, flexible/rigid reports (product code FGB) death is recorded in 0.1% and malfunction in 89.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are no display/image (17.2%), device displays incorrect message (7.3%) and unsealed device packaging (5.7%). The patient problems coded most often are urinary tract infection, pain and sepsis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 6,977 reports carrying product code FGB. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| No display/image | 33 | 17.2% | 3.3% |
| Device displays incorrect message | 14 | 7.3% | 0.2% |
| Unsealed device packaging | 11 | 5.7% | 0.2% |
| Breakthe device broke | 7 | 3.6% | 16.2% |
| Failure to power up | 6 | 3.1% | 0.1% |
| Poor quality image | 6 | 3.1% | 2.2% |
| Contamination | 4 | 2.1% | 1.2% |
| Mechanical jam | 4 | 2.1% | 1.6% |
| Positioning problem | 4 | 2.1% | 0.4% |
| Electrical /electronic property probleman electrical or electronic problem | 3 | 1.6% | 0% |
| Material separation | 3 | 1.6% | 1.6% |
| Defective devicethe device was defective | 2 | 1% | 0.3% |
| Device contamination with chemical or other material | 2 | 1% | 0.3% |
| Difficult to advance | 2 | 1% | 0.1% |
| Activation, positioning or separation problem | 1 | 0.5% | 0% |
| Communication or transmission problemthe device could not communicate or transmit | 1 | 0.5% | 0% |
| Connection problema connection problem | 1 | 0.5% | 0.1% |
| Difficult to insertthe device was hard to insert | 1 | 0.5% | 0.2% |
| Erratic or intermittent display | 1 | 0.5% | 1.3% |
| Failure to advance | 1 | 0.5% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Urinary tract infectionbladder or urinary infection | 33 | 17.2% |
| Painpain, site not specified | 9 | 4.7% |
| Sepsisa severe body-wide response to infection | 9 | 4.7% |
| Renal failurekidney failure | 7 | 3.6% |
| Fever | 5 | 2.6% |
| Hemorrhage/blood loss/bleeding | 5 | 2.6% |
| Nauseafeeling sick | 4 | 2.1% |
| Hematuria | 3 | 1.6% |
| Inflammationinflammation | 3 | 1.6% |
| Laceration(s) | 3 | 1.6% |
| Perforation | 3 | 1.6% |
| Urinary retentionbeing unable to empty the bladder | 3 | 1.6% |
| Abscessa collection of pus | 2 | 1% |
| Swelling/ edema | 2 | 1% |
| Arrhythmia | 1 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | LithoVue | Product code FGB | All MAUDE reports |
|---|---|---|---|
| Reports | 192 | 6,977 | 26,136,888 |
| Share of that pool | — | 2.8% | 0% |
| Classified as death, per 1,000 reports | 0 | 1 | 9 |
| Classified as injury | 34.9% | 10.1% | 36.2% |
| Classified as malfunction | 64.6% | 89.3% | 62.3% |
| Filed by the manufacturer | 77.6% | 95.8% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code FGB
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Uretero-Reno Videoscope | 3,269 | 1,862 | 0% |
| Uretero-Reno Fiberscope | 1,778 | 1,053 | 0% |
| Forceps/Irrigation Plug Isolated Type | 356 | 2 | 0.8% |
| Video Uretero-Renoscope FLEX-XC1 | 243 | 172 | 0% |
| Karl Storz | 633 | 0 | 2.1% |
| Olympus | 2,240 | 9 | 2.5% |
| Endoeye Flex Deflectable Videoscope | 8,062 | 2,245 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about LithoVue reports
How many FDA reports name LithoVue?
192 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 18 in the latest 12 months.
What kinds of events are reported?
malfunction (64.6%) and injury (34.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
no display/image (17.2%), device displays incorrect message (7.3%), unsealed device packaging (5.7%), break (3.6%) and failure to power up (3.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (77.6%) and voluntary reports (2.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that LithoVue was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.